Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen lipid soft gel versus standard ibuprofen soft gel for episodic knee pain
2014-004254-33Phase 3Completed
- Sponsor
- Infirst Healthcare
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen (3 arms), sponsored by Infirst Healthcare. Primary endpoint: Change from baseline in WOMAC pain score after 5 days of treatment. Started Dec 2014; status: completed.
02
Drugs
ibuprofen
Beyond the preview
Go deeper on 2014-004254-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004254-33.